Evidence map›Paper›PMID 31884710›Full record

ArticleJournal of applied toxicology : JAT2020

Comparison of tris(2-ethylhexyl) phosphate and di(2-ethylhexyl) phosphoric acid toxicities in a rat 28-day oral exposure study.

Guillaume Pelletier, Marc Rigden, Gen Sheng Wang, Don Caldwell, Shabana Siddique, Karen Leingartner, Ivana Kosarac, Sabit Cakmak, Cariton Kubwabo

Open access · hybridAbstract read
In one paragraph

Article in Journal of applied toxicology : JAT, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 27 citations in OpenAlex.

  1. A mixture of organophosphate esters sex-specifically impacts monocyte-macrophages in Sprague-Dawley rats.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  2. In vivo safety evaluation method for nanomaterials for cancer therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Guillaume PelletierHazard Identification Division, Environmental Health Science and Research Bureau, Health Canada, Ottawa, Canada.ORCID 0000-0002-4200-4515
Marc RigdenHazard Identification Division, Environmental Health Science and Research Bureau, Health Canada, Ottawa, Canada.
Gen Sheng WangScientific Service Division, Health Product and Food Branch, Health Canada, Ottawa, Canada.
Don CaldwellScientific Service Division, Health Product and Food Branch, Health Canada, Ottawa, Canada.
Shabana SiddiqueExposure and Biomonitoring Division, Environmental Health Science and Research Bureau, Health Canada, Ottawa, Canada.
Karen LeingartnerHazard Identification Division, Environmental Health Science and Research Bureau, Health Canada, Ottawa, Canada.
Ivana KosaracResearch Division, Tobacco Control Directorate, Health Canada, Ottawa, Canada.
Sabit CakmakPopulation Studies Division, Environmental Health Science and Research Bureau, Health Canada, Ottawa, Canada.ORCID 0000-0001-9921-2107
Cariton KubwaboExposure and Biomonitoring Division, Environmental Health Science and Research Bureau, Health Canada, Ottawa, Canada.ORCID 0000-0001-6150-047X
Health Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tris(2-ethylhexyl) phosphate (TEHP, CAS no. 78-42-2) is a plasticizer and a flame retardant, while di(2-ethylhexyl) phosphoric acid (DEHPA, CAS no. 298-07-7) is an oil additive and extraction solvent. Publicly-available information on repeated exposure to these two related organophosphate compounds is fragmentary. Hence, adult male and female Fischer rats were exposed to TEHP (300, 1000 and 3000 mg/kg body weight [BW]/day) or DEHPA (20, 60 and 180 mg/kg BW/day) by gavage for 28 consecutive days, to assess and compare their toxicities. Although significantly impaired BW gains and evidence of TEHP enzymatic hydrolysis to DEHPA were observed only in males, exposures to the highest TEHP and DEHPA doses often resulted in similar alterations of hematology, serum clinical chemistry and liver enzymatic activities in both males and females. The squamous epithelial hyperplasia and hyperkeratosis observed in the non-glandular forestomach of rats exposed to the middle and high DEHPA doses were most likely caused by the slightly corrosive nature of this chemical. Although tubular degeneration and spermatid retention were observed only in the testes of males exposed to the highest TEHP dose, numerous periodic acid-Schiff stained crystalline inclusions were observed in testis interstitial cells at all TEHP dose levels. No-observed-adverse-effect levels for TEHP and DEHPA are proposed, but the lower serum pituitary hormone levels resulting from TEHP and DEHPA exposures and the perturbations of testicular histology observed in TEHP-treated males deserve further investigation. Improved characterization of the toxicity of flame retardants will contribute to better informed substitution choices for legacy flame retardants phased-out over health concerns.

Indexed as

Administration, OralAnimalsBiomarkersFemaleFlame RetardantsLiverMaleNo-Observed-Adverse-Effect LevelOrganophosphatesOrgan SizePlasticizersRats, Inbred F344Risk AssessmentSolventsTestisTime FactorsBiomarkersdi-2-(ethylhexyl)phosphoric acidFlame RetardantsOrganophosphatesPlasticizersSolventstris(2-ethylhexyl)phosphateDi(2-ethylhexyl) phosphoric acidin vivo toxicityorganophosphate flame retardantrattesticular toxicityTris(2-ethylhexyl) phosphate

Identifiers

PMID31884710
PMCPMC7216891
OpenAlexW2997976213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.